Skip to content

OS Therapies OSTX Prepaid & Other Current

Prepaid & Other Current at other companies

Immunome logo
ImmunomeIMNM
$11.62M+100%
CTO
Citius Oncology, Inc.CTOR
$221.11K-91.8%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$6.69M+265%
WHW
Whitehawk Therapeutics, Inc. Common StockWHWK
$2.51M+61.4%

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: OS Therapies’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's prepaid & other current?
OS Therapies (OSTX) reported prepaid & other current of $63.08K in Q4 2025.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.